Tracon Pharmaceuticals Inc Expected To Post A Loss Of 26 Cents A Share: Earnings Preview

TRACON Pharmaceuticals

09/05/2023 03:03

* TRACON Pharmaceuticals Inc  TCON.OQ   TCON.O  is expected
to show no change in quarterly revenue when it reports 
results on May 10. 
    * 
    * ​Refinitiv's mean analyst estimate for TRACON
Pharmaceuticals
Inc is for a loss of 26 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for TRACON
Pharmaceuticals Inc is $8​, above​ its last closing price
of $0.73. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.27       -0.27      -0.31     Missed  -14.8
 Sep. 30 2022  -0.28       -0.28      -0.30     Missed  -6.2
 Jun. 30 2022  -0.36       -0.37      -0.31     Beat    16.8​
 Mar. 31 2022  -0.42       -0.42      -0.48     Missed  -15
 ​​Dec.        -0.36       -0.35      -0.40     Missed  -13.4
 31 2021                                                
 Sep. 30 2021  -0.32       -0.32      -0.38     Missed  -17.2​
 Jun. 30 2021  -0.32       -0.31      -0.58     Missed  -86.2
 Mar. 31 2021  -0.30       -0.30      -0.33     Missed  -8.2
 This summary was machine generated May 9 at 02:02 GMT.  All
figures in US dollars  unless otherwise stated